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Abstract
Aims/hypothesis Twin and family studies have shown the
importance of genetic factors influencing fasting and 2 h
glucose and insulin levels. However, the genetics of the
physiological response to a glucose load has not been
thoroughly investigated.
Methods We studied 580 monozygotic and 1,937 dizygotic
British female twins from the Twins UK Registry. The
effects of genetic and environmental factors on fasting and
2 h glucose and insulin levels were estimated using
univariate genetic modelling. Bivariate model fitting was
used to investigate the glucose and insulin responses to a
glucose load, i.e. an OGTT.
Results The genetic effect on fasting and 2 h glucose and
insulin levels ranged between 40% and 56% after adjust-
ment for age and BMI. Exposure to a glucose load resulted
in the emergence of novel genetic effects on 2 h glucose
independent of the fasting level, accounting for about 55%
of its heritability. For 2 h insulin, the effect of the same
genes that already influenced fasting insulin was amplified
by about 30%.
Conclusions/interpretation Exposure to a glucose challenge
uncovers new genetic variance for glucose and amplifies
the effects of genes that already influence the fasting insulin
level. Finding the genes acting on 2 h glucose indepen-
dently of fasting glucose may offer new aetiological insight
into the risk of cardiovascular events and death from all
causes.
Keywords Bivariategeneticmodelling.Gene×
environmentinteraction.Heritability.Insulin.Oralglucose
tolerance test.Twinstudy
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Introduction
Insulin resistance is the condition in which normal amounts
of insulin are inadequate to produce a sufficient response
from fat, muscle and liver cells. With increasing insulin
resistance, blood glucose levels increase, eventually leading
to type 2 diabetes [1]. It is now realised that, together with
abdominal obesity, insulin resistance plays a principal role
in initiating and perpetuating the pathological manifesta-
tions of the metabolic syndrome [2].
The gold standard for the investigation and quantification
of insulin resistance employs an euglycaemic clamp tech-
nique [3]. Given the complexity of the clamp technique, it
israrelyused inclinical practice orepidemiological research.
Instead,the OGTTisoften used tomeasureinsulinresistance
and diagnose diabetes mellitus [4].
Twin studies have been conducted to study the contri-
bution of genetic factors in the pathogenesis of diabetes
mellitus and metabolic syndrome. They have demonstrated
significant heritable influence on glucose and insulin values,
and on insulin resistance and beta cell function calculated
from fasting levels or OGTT values [5–15], but there is no
clear consensus on the degree to which genes explain the
variance of fasting and 2 h glucose and insulin levels. Most
studies have focused on the OGTT and have reported
heritabilities of fasting and 2 h glucose and insulin ranging
from 12% to 62% (see Electronic Supplementary Material
[ESM] Table 1). However, these studies were modest in
size and none of them analysed the glucose and insulin
responses to the glucose load in a multivariate fashion.
Such an approach provides insight into the genetics of the
response to this experimentally induced environmental
challenge (i.e. gene × environment interaction) and allows
investigation of a number of interesting questions [16–18].
Examples of such questions are (1) whether the influence of
genes that act on the fasting level is amplified (or dampened)
after exposure to a glucose load, and (2) whether new genetic
variance emerges as a result of exposure to the glucose
challenge. Investigating these questions would be extremely
helpful in designing gene-finding studies, and may aid, for
example, the selection of candidate genes and the determi-
nation of which phenotype to measure.
In this study we used a bivariate analysis of fasting and
2 h levels to investigate the 2 h glucose and insulin
responses to the glucose load of an OGTT in a large sample
of female twins.
Methods
Subjects
The Twins UK Registry comprises unselected, mostly
female volunteers taken from the general population
through national media campaigns in the UK [19]. Written
informed consent was obtained from all participants before
they entered the study, which was approved by the local
research ethics committee.
Zygosity, body composition, and biochemical analyses
Zygosity was determined by the standardised questionnaire
and confirmed by a combination of DNA analyses which
included full genome scans, the ABI FESTR kit (Perkin-
Elmer Applied Biosystems,Warrington, UK) and the QUAD
system (Forensic Science Services, Birmingham, UK).
Height was measured to the nearest 0.5 cm using a wall-
mounted stadiometer. Weight (light clothing only) was
measured to the nearest 0.1 kg using digital scales. BMI
was calculated as weight divided by height squared (kg/m
2).
Avenous blood sample was taken between 08.00 and 10.00
hours after an overnight fast. Within 1 h of collection, the
samples were centrifuged to obtain platelet-poor plasma.
Fasting insulin was measured by immunoassay (Abbott
Laboratories, Maidenhead, UK) and glucose was measured
with an Ektachem 700 multichannel analyser using an
enzymatic colorimetric slide assay (Johnson and Johnson
Clinical Diagnostic Systems, Amersham, UK). A subsample
of twins underwent an OGTT for which glucose and insulin
levels were measured before and 2 h after a 75 g oral glucose
load.
Analytical approach
The aims of our analyses were twofold: first, to estimate the
influence of genetic and environmental factors on fasting
and 2 h glucose and fasting and 2 h insulin using univariate
genetic modelling; and second, based on the results of
univariate genetic modelling, to use bivariate model fitting
to investigate the glucose and insulin responses to the 75 g
oral glucose load.
Univariate genetic modelling Details of univariate model
fitting to twin data have been described elsewhere [20, 21].
In short, the technique is based on comparison of the
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twin pairs and allows separation of the observed phenotypic
variance into additive (A) or dominant (D) genetic compo-
nents and shared (C) or unique (E) environmental compo-
nents. The last also contains measurement error. Dividing
each of these components by the total variance yields the
different standardised components of variance. For example,
heritability (h
2) can be defined as the proportion of the total
variance attributable to additive genetic variance.
Bivariate genetic modelling We used a bivariate analysis of
fasting and 2 h levels of glucose or insulin corresponding to
the path diagram shown in Fig. 1. This path diagram
depicts the typical structural equation modelling approach
to twin data [22]. In this approach, the variance in the
observed traits (e.g. fasting glucose and 2 h glucose) is
decomposed into latent additive genetic, shared environ-
mental and unique environmental components. The model
is identified because correlations between latent genetic and
environmental factors are known for monozygotic and
dizygotic twins from biometrical genetic theory. The model
implied by the path diagram specifies an expected
covariance matrix. Estimates for the path coefficients, i.e.
the model parameters (e.g. a11, c11, e11), are obtained by
using a fit function that minimises the difference between
the observed covariance matrix and the expected covariance
matrix implied by the model.
The relative contribution of genetic variance to the total
variance in the fasting glucose level, also known as its
heritability, is the effect of the genetic factor A (shown in
Fig. 1), and is obtained as the ratio a2
11

a2
11 þ c2
11 þ e2
11

.
The heritability of 2 h glucose level is the summed effect of
the genetic factors A and As, and is obtained as the ratio of
genetic to total variance, or a2
21 þ a2
22
 
a2
21 þ a2
22 þ c2
21þ

c2
22 þ e2
21 þ e2
22Þ. When going from fasting to the 2 h level,
the effects of the set of genes acting on fasting levels may
be amplified (a21>a11) or dampened (a21<a11) in response
to the glucose load. In addition, entirely new genetic
variation may emerge only in response to the glucose load,
depicted by factor As. In this case, the path coefficient a22
will differ significantly from zero (a22>0). This part of the
total heritability represents the influence of novel genetic
effects that are expressed only during challenge and is equal
to a2
22

a2
21 þ a2
22 þ c2
21 þ c2
22 þ e2
21 þ e2
22

. Both amplifi-
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Fig. 1 Bivariate twin model for genetic and environmental influences
on fasting and 2 h glucose. Biometrical genetic theory specifies that
the additive genetic factors (denoted by A and As) of monozygotic
(MZ) twins are perfectly correlated (1.0), whereas those of dizygotic
(DZ) twins have a correlation of 0.5. Common environmental factors
shared by twins from the same family (denoted by C and Cs) have a
correlation of unity for both types of twin, whereas the unique
environmental influences (E and Es) are always uncorrelated. Path
coefficient a11 quantifies the effect of genetic influence A on the
fasting level, a21 quantifies the effect of A on the 2 h level, and a22
quantifies the effect of emergent genes in As on the 2 h level.
Similarly, path coefficients c11, e11, c21 and e21 quantify the effects of
common and unique environmental influences C and E on fasting and
2 h levels. c22 and e22 quantify the effect of emergent environmental
influences in Cs and Es on 2 h level. The influence of dominance
variance D was also investigated, but for clarity it is not shown.
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environment interaction [18].
Before genetic analysis, all variables were log-
transformed to obtain better approximations of normal
distributions. Effects of age (model 1) and age and BMI
(model 2) were regressed out for all variables before using
the residuals in model fitting. Models were fitted to the raw
data using normal maximum likelihood theory, allowing the
use of information for the estimation of variance (but not
covariance) provided by unpaired twin observations and/or
fasting-only observations.
For genetic modelling, a series of submodels nested
within the full-parameter ACE or ADE model were fitted to
the variance–covariance matrices. The significances of
variance components A, C/D and E were assessed by
testing the deterioration in model fit after each component
was dropped from the full ACE or ADE model. Based on
the results of univariate genetic modelling, a bivariate
decomposition (Fig. 1) was used to model the covariance
between fasting and the 2 h level of glucose or insulin.
Emergence of new genetic variance was tested using a
submodel that constrained the a22 parameter to zero.
Amplification (or dampening) of genetic influence was tested
using a submodel that constrained a21 and a11 to be equal.
Standard hierarchic χ
2 tests were used to select the best-
fitting model at a significance level of p<0 . 0 5i nc o m b i n a t i o n
with Akaike’s information criterion (AIC=χ
2−2df). The
model with the lowest AIC reflects the best balance between
goodness of fit and parsimony [20].
Preliminary analyses were done using STATA 10 (Stata,
College Station, TX, USA). Genetic modelling was carried
out with Mx, a computer program specifically designed for
the analysis of twin and family data [23].
Results
General characteristics
The study cohort consisted of female twins whose fasting or
2 h glucose level or insulin data were available. A total of
226 non-fasting participants (≤8 h), and 33 patients with
diabetes were excluded from the analysis. The total number
of twins included in the final analysis was 580 monozygotic
twins (280 twin pairs and 20 unpaired twins) and 1,937
dizygotic twins (933 twin pairs and 71 unpaired twins). Of
these participants, 308 monozygotic twins (150 twin pairs
and eight unpaired twins) and 891 dizygotic twins (431
twin pairs and 29 unpaired twins) underwent an OGTT and
had measurements of 2 h glucose available. Most of these
twins [181 monozygotic (88 twin pairs and five unpaired
twins) and 631 dizygotic twins (310 twin pairs and 11
unpaired twins)] also had their 2 h insulin measured.
General characteristics of these twins are shown in Table 1.
Fasting and 2 h glucose and insulin were very similar in the
two zygosity groups; monozygotic twins were slightly older
and had a lower BMI than dizygotic twins. However, we
adjusted for age and BMI in our analyses (see blow).
Univariate genetic modelling
Table 2 presents the twin correlations for the two zygosity
groups adjusted for age and age and BMI, respectively. For
all measures, intraclass correlations in monozygotic twins
were consistently larger than in dizygotic twins, indicating
an important contribution of genetic factors.
This pattern was confirmed by the univariate model
fitting. Parameter estimates of the best-fitting univariate
models and their 95% confidence interval (CI) are shown in
Table 3. There were significant genetic components for all
variables, whether after adjustment for age or after
adjustment for age and BMI. For fasting glucose and
fasting insulin, a full ACE model was chosen as the best-
fitting model, on the basis of a hierarchic χ
2 test and lowest
AIC. After adjustment for age, the heritabilities of fasting
glucose and fasting insulin were estimated at 38% and 45%,
respectively. In the best-fitting model for 2 h glucose and
2 h insulin, C could be dropped without deterioration in fit
(χ
2(1)=0.0, p=1.0). The heritabilities of 2 h glucose and
insulin were estimated at 42% and 51% respectively.
Heritability estimates after additional adjustment for BMI
decreased slightly except for the heritability of fasting
Characteristic Monozygotic Dizygotic
n Mean±SD n Mean±SD
Age (years) 580 49.2±14.1 1937 46.9±11.8
BMI (kg/m
2) 580 24.4±3.8 1937 25.1±4.6
Fasting glucose (mmol/l) 580 4.5±0.6 1937 4.5±0.5
Fasting insulin (pmol/ml) 430 49.3±43.5 1744 47.3±34.0
2 h glucose (mmol/l) 308 5.2±1.6 891 5.2±1.1
2 h insulin (pmol/ml) 181 238.2±158.6 631 234.7±177.0
Table 1 Characteristics of
monozygotic and dizygotic
twins in the study sample
n, number of participants (non-
fasting participants [≤8 h] and
patients with diabetes were
excluded)
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0.35. Dominant genetic influences were tested for all
variables (ADE vs AE) but never contributed significantly
(data not shown).
Bivariate genetic modelling
Based on the results of univariate model fitting, using the
model depicted in Fig. 1, a series of submodels nested
within the full model were tested for both glucose and
insulin. Guided by our univariate model fitting results we
first tested whether we could drop the influence of C on 2 h
glucose and insulin (i.e. c21 and c22). Subsequently we
tested the significance of the genetic correlation (a21), novel
genetic effects (a22) and unique environmental correlation
(e21). The results showed that c21 and c22 could be dropped
with no deterioration in model fit for both glucose and
insulin (ESM Table 2, model 2). For glucose, the path
coefficients a21 (model 3) and a22 (model 4) could not be
dropped, which means there was a significant genetic effect
of A on 2 h glucose and a significant novel genetic effect
(As) on 2 h glucose. Finally, e21 (model 5) could not be
dropped without a deterioration in model fit. For insulin,
the path coefficient a21 could not be dropped (model 3),
which means there was a significant effect of A on 2 h
insulin level. However, a22 and e21 could be dropped
without worsening the model fit, meaning there was no
significant novel genetic effect in response to the glucose
load, and no significant unique environmental correlation
between fasting and 2 h insulin.
Parameter estimates of best-fitting bivariate models are
shown in Table 4. Significant heritability was found for
fasting and 2 h glucose and insulin. After adjustment for
age and BMI, the heritability of 2 h glucose (0.42) was
similar to that of fasting glucose (0.40). The heritability of
2 h insulin (0.56) was a little higher than that of fasting
insulin (0.44). The parameter estimates after adjustment for
age were similar to those that were additionally adjusted for
BMI.
Table 5 presents additional characteristics of best-fitting
bivariate models for the response to an oral glucose load. A
common set of genes was found to influence both fasting
and 2 h levels of glucose. Similar results were obtained for
insulin. This factor represents genes acting on both fasting
and 2 h levels and corresponds to factor A in Fig. 1.
Amplification of the effect of genes that already influence
the fasting glucose level was not significant (after adjust-
ment for age and BMI, Δχ
2(1)=0.93, p=0.34), while
exposure to a glucose load significantly amplified the effect
of genes that already influence fasting insulin (after
adjustment for age and BMI, Δχ
2(1)=13.38, p=0.0003).
Furthermore, for glucose, exposure to a glucose load
uncovered new genetic variance corresponding to factor
As in Fig. 1; the specific heritability due to genes emerging
Table 2 Intraclass correlations (95% CI) for monozygotic and dizygotic twins
Measure No. twin pairs Age-adjusted Age- and BMI-adjusted
Monozygotic Dizygotic Monozygotic Dizygotic Monozygotic Dizygotic
Fasting glucose (mmol/l) 280 933 0.72 (0.66–0.77) 0.50 (0.46–0.55) 0.72 (0.66–0.78) 0.52 (0.47–0.56)
Fasting insulin (pmol/ml) 206 837 0.65 (0.57–0.73) 0.37 (0.31–0.43) 0.63 (0.55–0.71) 0.38 (0.33–0.44)
2 h glucose (mmol/l) 150 431 0.48 (0.36–0.60) 0.16 (0.06–0.25) 0.47 (0.34–0.59) 0.15 (0.06–0.25)
2 h insulin (pmol/ml) 88 310 0.52 (0.36–0.67) 0.24 (0.14–0.35) 0.49 (0.34–0.65) 0.24 (0.14–0.35)
Measure h
2 (95% CI) c
2 (95% CI) e
2 (95% CI)
Age-adjusted
Fasting glucose (mmol/l) 0.38 (0.25–0.51) 0.32 (0.22–0.42) 0.30 (0.25–0.35)
Fasting insulin (pmol/ml) 0.45 (0.26–0.63) 0.16 (0.02–0.29) 0.39 (0.33–0.48)
2 h glucose (mmol/l) 0.42 (0.31–0.52) 0.58 (0.48–0.69)
2 h insulin (pmol/ml) 0.51 (0.39–0.62) 0.49 (0.38–0.62)
Age- and BMI-adjusted
Fasting glucose mmol/l 0.37 (0.24–0.50) 0.34 (0.24–0.43) 0.29 (0.25–0.35)
Fasting insulin (pmol/ml) 0.35 (0.15–0.53) 0.22 (0.09–0.36) 0.43 (0.36–0.51)
2 h glucose (mmol/l) 0.41 (0.30–0.51) 0.59 (0.49–0.70)
2 h insulin (pmol/ml) 0.50 (0.37–0.61) 0.50 (0.39–0.63)
Table 3 Parameter estimates
and 95% CIs of the best-fitting
univariate models
1052 Diabetologia (2009) 52:1048–1055was 23% (95% CI 0.06–0.36). Comparing this with the
total heritability of 2 h glucose, which was 42%, the genetic
effect due to genes emerging accounted for about 55% of
the total heritability of 2 h glucose. For insulin, no
significant influence of new genetic variance was found.
Discussion
In this study, we estimated the relative influences of genetic
and environmental factors on fasting and 2 h glucose and
insulin levels in a large sample of British female twins.
Furthermore, we used bivariate model fitting to investigate
the glucose and insulin response to a 75 g oral glucose load.
We found that there were significant genetic components
for fasting and 2 h glucose and insulin levels. Key findings
of this study derived from the bivariate model fitting are as
follows: (1) a common set of genes was found to influence
both fasting and 2 h levels of glucose, and similar results
were obtained for insulin; (2) for glucose, exposure to a
glucose load uncovered new genetic variance; (3) for insulin,
a glucose challenge significantly amplified the effect of
genes that already influence the fasting insulin level.
Previous twin studies showed a significant effect of
genetic factors on fasting and 2 h glucose and insulin levels
[5, 6, 8–11]. In this British female twin cohort, we found
significant effects of genetic factors on fasting and 2 h
glucose and insulin after adjustment for age and additional
adjustment for BMI, which are largely in agreement with
previous studies [9, 11]. We found that heritability
estimates showed a considerable drop, of around 10%, for
fasting insulin after additional adjustment for BMI. This
indicates that part of the heritability for fasting insulin can
be attributed to genes for obesity. The fat mass and obesity
associated gene (FTO) is a practical example of such a
gene. Initially discovered as a type 2 diabetes gene, it was
later found that its effect was mediated by obesity [24]. In
fitting the univariate model, we found that the best-fitting
model for fasting glucose and insulin was the ACE model,
which is different from the best-fitting AE model for fasting
glucose and insulin that others found [9, 11]. This might be
explained by our much larger sample size, which provided
enough power to detect the effect of a shared environment.
In designing gene-finding studies, it may be helpful to
have prior knowledge from twin studies guiding the choice
of phenotypesand thetype ofgenes tolook for,i.e.amplified
or emerging genes. For instance, if only amplification had
been found with small effects on total genetic variance,
adding OGTT to the experimental protocol would not be
worthwhile. Vice versa, if new genetic variance emerges
Table 4 Parameter estimates (95% CI) of best-fitting bivariate models
Measure Fasting level 2 h level
h
2 (95% CI) c
2 (95% CI) e
2 (95% CI) h
2 (95% CI) e
2 (95% CI)
Age-adjusted
Glucose 0.42 (0.29–0.54) 0.29 (0.19–0.39) 0.29 (0.25–0.35) 0.43 (0.32–0.53) 0.57 (0.47–0.68)
Insulin 0.49 (0.40–0.58) 0.14 (0.07–0.21) 0.37 (0.32–0.43) 0.57 (0.47–0.67) 0.43 (0.33–0.53)
Age- and BMI-adjusted
Glucose 0.40 (0.28–0.53) 0.31 (0.21–0.40) 0.29 (0.24–0.34) 0.42 (0.31–0.52) 0.58 (0.48–0.69)
Insulin 0.44 (0.35–0.54) 0.17 (0.09–0.24) 0.39 (0.34–0.45) 0.56 (0.45–0.66) 0.44 (0.34–0.55)
Table 5 Bivariate heritability estimates of the response to an OGTT of best-fitting models
Measure Fasting h
2
(95% CI)
2hh
2 (95% CI) Amplification of genes acting
on fasting level
Specific h
2 due to genes emerging
a
(95% CI)
Age-adjusted
Glucose 0.42 (0.29–0.54) 0.43 (0.32–0.53) NS 0.24 (0.07–0.36)
Insulin 0.49 (0.40–0.58) 0.57 (0.47–0.67) a21/a11=1.31 NS
Age- and BMI-adjusted
Glucose 0.40 (0.28–0.53) 0.42 (0.31–0.52) NS 0.23 (0.06–0.36)
Insulin 0.44 (0.35–0.55) 0.56 (0.45–0.66) a21/a11=1.46 NS
aHeritability estimate for genes emerging on exposure to OGTT
NS, not significant
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found when the system is challenged environmentally.
In our study, for insulin, no new genetic variance was
found as a result of exposure to a glucose load. We
estimated specific heritabilities of only 0.06 (95% CI 0.00–
0.24) after adjustment for age and 0.00 (95% CI 0.00–0.21)
after additional adjustment for BMI. Thus, it is unlikely that
we missed the effects of emerging genes on 2 h insulin due
to power limitations of our study. For glucose, we found
that, exposure to a glucose load uncovered new genetic
variance, accounting for about 55% of the total heritability
of 2 h glucose. It would therefore be interesting if genes
were detected that acted on 2 h glucose distinct from those
acting on fasting glucose. The DECODE Study Group [25]
and Qiao et al. [26] found that asymptomatic diabetes, as
well as IGT defined by the 2 h glucose criterion alone,
increased the risk of death from cardiovascular and all
causes, independently of other known risk factors and the
level of fasting glucose, whereas mortality associated with
the fasting glucose concentration depended largely on the
level of 2 h glucose. They concluded that 2 h glucose was
superior to fasting glucose in assessing the risk of future
cardiovascular disease events and mortality from all causes.
This might be explained to some extent by the genetic
effects acting on 2 h glucose during exposure to a glucose
load being distinct from those acting on fasting glucose.
Genome-wide association studies have found susceptibility
loci associated with type 2 diabetes [27] and cardiovascular
disease [28], but no genome-wide association studies of 2 h
glucose have been conducted to date. Finding genes specific
to 2 h glucose would offer new aetiological insight into the
risk of cardiovascular events and death from all causes.
The study by Katoh et al. [11] is the only other study that
included bivariate analysis of OGTT data. They estimated
the genetic correlation coefficient between fasting insulin
and 2 h insulin levels through bivariate genetic analyses,
and found that they were influenced by a shared genetic
factor, which is in line with our finding. However they did
not investigate whether there is amplification or new
genetic variance emerging due to exposure to a glucose
load. Furthermore, they did not report bivariate results for
fasting and 2 h glucose in their study because of power
limitations.
To our knowledge, our study is the largest twin study to
report heritabilities of fasting and 2 h glucose and insulin.
These British female twins have been shown to be
comparable to the age-matched general population in the
UK in terms of disease-related and lifestyle characteristics
[29]. However, our results cannot necessarily be extrapo-
lated to males, as females may respond to a glucose load
differently from males [30].
In summary, our key findings are that a common set of
genes was found to influence fasting and 2 h glucose and
insulin levels, and that exposure to a 75 g oral glucose load
uncovers new genetic variance for glucose and amplifies
the effect of genes that already influence the fasting level of
insulin. This has clear implications for attempts to find the
genes influencing insulin resistance through linkage or
association approaches, and it would be useful to detect
genes acting on 2 h glucose distinct from genes acting on
fasting glucose.
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